Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Ceftazidime 500mg powder for solution for injection vials
0501021H0AAAAAA
|
Ceftazidime pentahydrate | Ceftazidime pentahydrate | Infections | No data available |
|
Cefuroxime 1.5g powder for solution for injection vials
0501021J0AAACAC
|
Cefuroxime sod (Parent) | Cefuroxime sodium | Infections | No data available |
|
Cefuroxime 125mg granules for oral suspension sachets
0501021K0AAADAD
|
Cefuroxime axetil | Cefuroxime axetil | Infections | No data available |
|
Cefuroxime 250mg powder for solution for injection vials
0501021J0AAAAAA
|
Cefuroxime sod (Parent) | Cefuroxime sodium | Infections | No data available |
|
Cefzil 250mg tablets
0501020AABBAAAA
|
Cefzil | Cefprozil | Infections | No data available |
|
Cefzil 250mg/5ml oral suspension
0501020AABBACAC
|
Cefzil | Cefprozil | Infections | No data available |
|
Cefzil 500mg tablets
0501020AABBABAB
|
Cefzil | Cefprozil | Infections | No data available |
|
Celance 1mg tablets
0409010P0BBACAC
|
Celance | Pergolide mesilate | Central Nervous System | No data available |
|
Celance 250microgram tablets
0409010P0BBABAB
|
Celance | Pergolide mesilate | Central Nervous System | No data available |
|
Celance 50microgram tablets
0409010P0BBAAAA
|
Celance | Pergolide mesilate | Central Nervous System | No data available |
|
Celance tablets 14 day starter pack
0409010P0BBADAE
|
Celance | Pergolide mesilate | Central Nervous System | No data available |
|
Celance tablets 30 day starter pack
0409010P0BBAEAE
|
Celance | Pergolide mesilate | Central Nervous System | No data available |
|
Celecoxib 400mg capsules
1001010AHAAADAD
|
Celecoxib | Celecoxib | Musculoskeletal and Joint Diseases | No data available |
|
Celecoxib 50mg/5ml oral suspension
1001010AHAAAEAE
|
Celecoxib | Celecoxib | Musculoskeletal and Joint Diseases | No data available |
|
Celiprolol 200mg/5ml oral suspension
020400060AAACAC
|
Celiprolol hydrochloride | Celiprolol hydrochloride | Cardiovascular System | No data available |
|
CellCept 500mg powder for solution for infusion vials
0802010M0BBADAH
|
CellCept | Mycophenolate mofetil | Malignant Disease and Immunosuppression | No data available |
|
Cellona shoe children paediatric size 25-30
21290000132
|
Cellona shoe children paediatric size 25-30 | Pressure Offloading Device | Appliances | No data available |
|
Cellosene cellulose wadding
20180000001
|
Cellosene cellulose wadding | Cellulose Wadding BP 1988 | Dressings | No data available |
|
CelluDress - PHMB dressing 10cm x 10cm square
20030200216
|
CelluDress - PHMB dressing 10cm x 10cm square | Wound Management & Other Dressings | Dressings | No data available |
|
CelluDress dressing 10cm x 10cm
20030100592
|
CelluDress dressing 10cm x 10cm | Wound Management & Other Dressings | Dressings | No data available |
|
CelluDress dressing 10cm x 15cm
20030100593
|
CelluDress dressing 10cm x 15cm | Wound Management & Other Dressings | Dressings | No data available |
|
CelluDress dressing 10cm x 20cm
20030100594
|
CelluDress dressing 10cm x 20cm | Wound Management & Other Dressings | Dressings | No data available |
|
CelluDress dressing 20cm x 25cm
20030100596
|
CelluDress dressing 20cm x 25cm | Wound Management & Other Dressings | Dressings | No data available |
|
CelluDress dressing 20cm x 30cm
20030100597
|
CelluDress dressing 20cm x 30cm | Wound Management & Other Dressings | Dressings | No data available |
|
Celluloid colostomy cup with sponge/solid rim, large
23755307502
|
Celluloid colostomy cup with sponge/solid rim, large | Pressure Plates/Shields | Stoma Appliances | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.